{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:58:43Z","timestamp":1793663923540,"version":"4.5.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The mechanisms underpinning Moyamoya disease (MMD) remain unclear, and effective biomarkers remain unknown. The purpose of this study was to identify novel serum biomarkers of MMD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum samples were collected from 23 patients with MMD and 30 healthy controls (HCs). Serum proteins were identified using tandem tandem-mass-tag (TMT) labeling combined with liquid chromatography-tandem mass spectrometry (LC-MS\/MS). Differentially expressed proteins (DEPs) in the serum samples were identified using the SwissProt database. The DEPs were assessed using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database, Gene Ontology (GO), and protein-protein interaction (PPI) networks, and hub genes were identified and visualized using Cytoscape software. Microarray datasets GSE157628, GSE189993, and GSE100488 from the Gene Expression Omnibus (GEO) database were collected. Differentially expressed genes (DEGs) and differentially expressed miRNAs (DE-miRNAs) were identified, and miRNA targets of DEGs were predicted using the miRWalk3.0 database. Serum apolipoprotein E (APOE) levels were compared in 33 MMD patients and 28 Moyamoya syndrome (MMS) patients to investigate the potential of APOE to be as an MMD biomarker.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 85 DEPs, of which 34 were up- and 51 down-regulated. Bioinformatics analysis showed that some DEPs were significantly enriched in cholesterol metabolism. A total of 1105 DEGs were identified in the GSE157628 dataset (842 up- and 263 down-regulated), whereas 1290 were identified in the GSE189993 dataset (200 up- and 1,090 down-regulated). The APOE only overlaps with the upregulated gene expression in Proteomic Profiling and in GEO databases. Functional enrichment analysis demonstrated that APOE was associated with cholesterol metabolism. Moreover, 149 miRNAs of APOE were predicted in the miRWalk3.0 database, and hsa-miR-718 was the only DE-miRNA overlap identified in MMD samples. Serum APOE levels were significantly higher in patients with MMD than in those without. The performance of APOE as an individual biomarker to diagnose MMD was remarkable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We present the first description of the protein profile of patients with MMD. APOE was identified as a potential biomarker for MMD. Cholesterol metabolism was found to potentially be related to MMD, which may provide helpful diagnostic and therapeutic insights for MMD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1156894","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T05:33:21Z","timestamp":1683610401000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["APOE as potential biomarkers of moyamoya disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Haibin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erming","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1474-4422(22)00165-X","article-title":"Moyamoya disease: diagnosis and interventions","volume":"21","author":"Ihara","year":"2022","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.molmed.2022.08.009","article-title":"Moyamoya disease emerging as an immune-related angiopathy","volume":"28","author":"Asselman","year":"2022","journal-title":"Trends Mol Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10143-018-0994-5","article-title":"Progress in moyamoya disease","volume":"43","author":"Shang","year":"2020","journal-title":"Neurosurg Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1161\/STROKEAHA.113.004160","article-title":"Epidemiology of moyamoya disease in Taiwan: a nationwide population-based study","volume":"45","author":"Chen","year":"2014","journal-title":"Stroke."},{"key":"B5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.clineuro.2009.11.009","article-title":"Epidemiological and clinical features of Moyamoya disease in Nanjing, China","volume":"112","author":"Miao","year":"2010","journal-title":"Clin Neurol Neurosurg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1038\/s41467-021-26061-w","article-title":"Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity","volume":"12","author":"Thery","year":"2021","journal-title":"Nat Commun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3390\/ijms22041696","article-title":"Pathological circulating factors in moyamoya disease","volume":"22","author":"Fang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-022-02238-4","article-title":"Identification of immune-infiltrated hub genes as potential biomarkers of Moyamoya disease by bioinformatics analysis","volume":"17","author":"Jin","year":"2022","journal-title":"Orphanet J Rare Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11011-020-00616-0","article-title":"Circulating sortilin levels are associated with inflammation in patients with moyamoya disease","volume":"36","author":"Han","year":"2021","journal-title":"Metab Brain Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1177\/0271678X18768443","article-title":"Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease","volume":"38","author":"Blecharz-Lang","year":"2018","journal-title":"J Cereb Blood Flow Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1177\/1747493016662039","article-title":"Caveolin-1 J, Ring finger protein 213, and endothelial function in Moyamoya disease","volume":"11","author":"Bang","year":"2016","journal-title":"Int J Stroke"},{"key":"B12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cca.2022.06.031","article-title":"TMT-based quantitative proteomics analysis and potential serum protein biomarkers for systemic lupus erythematosus","volume":"534","author":"Zhou","year":"2022","journal-title":"Clin Chim Acta."},{"key":"B13","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1021\/acs.jproteome.9b00676","article-title":"Discovery of potential serum protein biomarkers in ankylosing spondylitis using tandem mass tag-based quantitative proteomics","volume":"19","author":"Liu","year":"2020","journal-title":"J Proteome Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1227\/01.NEU.0000249275.87310.FF","article-title":"Expression of hypoxia-inducing factor-1 alpha and endoglin in intimal hyperplasia of the middle cerebral artery of patients with Moyamoya disease","volume":"60","author":"Takagi","year":"2007","journal-title":"Neurosurgery."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2176\/nmc.47.1","article-title":"Histological features of middle cerebral arteries from patients treated for Moyamoya disease","volume":"47","author":"Takagi","year":"2007","journal-title":"Neurol Med Chir."},{"key":"B17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3171\/2010.5.PEDS09505","article-title":"Diffuse and uncontrolled vascular smooth muscle cell proliferation in rapidly progressing pediatric moyamoya disease","volume":"6","author":"Reid","year":"2010","journal-title":"J Neurosurg Pediatr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2009.1.FOCUS08302","article-title":"Pathophysiology and genetic factors in moyamoya disease","volume":"26","author":"Achrol","year":"2009","journal-title":"Neurosurg Focus."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1161\/STROKEAHA.118.021888","article-title":"Cav-1 (Caveolin-1) and arterial remodeling in adult moyamoya disease","volume":"49","author":"Chung","year":"2018","journal-title":"Stroke."},{"key":"B20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbrc.2020.02.024","article-title":"Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NF\u03baB activation and apoptosis in an AAA+ domain-dependent manner","volume":"525","author":"Takeda","year":"2020","journal-title":"Biochem Biophys Res Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"113087","DOI":"10.1016\/j.bios.2021.113087","article-title":"Peptide-based electrochemical biosensors utilized for protein detection","volume":"180","author":"Vanova","year":"2021","journal-title":"Biosens Bioelectron."},{"key":"B22","doi-asserted-by":"publisher","first-page":"881954","DOI":"10.3389\/fnmol.2022.881954","article-title":"Transcriptomic profiling of intracranial arteries in adult patients with moyamoya disease reveals novel insights into its pathogenesis","volume":"15","author":"Xu","year":"2022","journal-title":"Front Mol Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/2021.6.FOCUS20870","article-title":"Transcriptome-wide analysis of intracranial artery in patients with moyamoya disease showing upregulation of immune response, and downregulation of oxidative phosphorylation and DNA repair","volume":"51","author":"Kanamori","year":"2021","journal-title":"Neurosurg Focus."},{"key":"B24","doi-asserted-by":"publisher","first-page":"104809","DOI":"10.1016\/j.nbd.2020.104809","article-title":"Beyond the CNS: the many peripheral roles of APOE","volume":"138","author":"Mart\u00ednez-Mart\u00ednez","year":"2020","journal-title":"Neurobiol Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.3171\/2015.5.JNS142973","article-title":"Association of apolipoprotein E gene polymorphism with small-vessel lesions and stroke type in moyamoya disease: a preliminary study","volume":"124","author":"Jang","year":"2016","journal-title":"J Neurosurg."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/ATVBAHA.111.222745","article-title":"Apolipoprotein E induces antiinflammatory phenotype in macrophages","volume":"31","author":"Baitsch","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ajhg.2014.01.018","article-title":"Loss of \u03b11f1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia","volume":"94","author":"Herv\u00e9","year":"2014","journal-title":"Am J Hum Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1161\/01.STR.24.12.1960","article-title":"Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease","volume":"24","author":"Masuda","year":"1993","journal-title":"Stroke."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.3390\/ijms19113479","article-title":"Apoprotein E and reverse cholesterol transport","volume":"19","author":"Getz","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00109-018-1632-y","article-title":"Cell-specific production, secretion, and function of apolipoprotein E","volume":"96","author":"Kockx","year":"2018","journal-title":"J Mol Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","article-title":"Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism","volume":"36","author":"Mahley","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11883-021-00933-4","article-title":"Apolipoprotein E and atherosclerosis","volume":"23","author":"Marais","year":"2021","journal-title":"Curr Atheroscler Rep."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1156894\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T05:33:29Z","timestamp":1683610409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1156894\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":32,"alternative-id":["10.3389\/fneur.2023.1156894"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1156894","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"article-number":"1156894"}}